Ex Parte HORNUNG et al - Page 5




          Appeal No. 2002-0278                                                        
          Application 08/797,674                                                      


                                       OPINION                                        
               With full consideration being given to the subject matter on           
          appeal, the Examiner’s rejections, and the arguments of                     
          Appellants and the Examiner, for the reasons stated infra, we               
          reverse the Examiner’s rejection of claims 1 through 13, 15                 
          through 18 and 24 through 32 under 35 U.S.C. § 102 based upon a             
          public use or sale of the invention, and we reverse the                     
          Examiner’s rejection of claims 1 through 3, 8, 24, 26, 27, 30 and           
          32 under 35 U.S.C. § 102 as being anticipated by Tan.                       
          Furthermore, we reverse the Examiner’s rejection of claims 4-7,             
          10 through 13, 15 through 17, 25 through 28 and 31 under                    
          35 U.S.C. § 103 as being unpatentable over Tan, and we reverse              
          the Examiner’s rejection of claims 9, 28 and 29 under 35 U.S. C.            
          § 103 as being unpatentable over Tan in view of IEEE SCI.                   
          Rejection Under 35 U.S.C. § 102 based upon a Public Use or Sale             
               Appellants point out that a declaration under oath by an               
          inventor pursuant to 37 CFR § 1.132 was filed stating that the              
          commercial activity did not comprise a response activation queue.           
          Appellants point out that independent claims 1, 10 and 24 define            
          a response activation queue, which is depicted in figure 2 as               
          item 210.  Appellants argue that the record shows that the                  


                                          5                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007